AASraw: Weight Loss Peptide Raw Powder/Vials
If you’re tired of yo-yo diets, endless cardio, and supplements that do NOTHING, it’s time to level up with research peptides that are changing the game. These aren’t your average fat burners – they’re GLP-1/GIP agonists straight out of clinical studies, helping people drop 15-30% body weight with appetite control, better insulin sensitivity, and sustained energy.
Semaglutide
Tirzepatide
Retatrutide
Cagrilintide
Cagrisema
Mazdutide
Have you ever used them? Feel free to leave your experience and feedback.
Efficacy for Weight Loss
Semaglutide: In the STEP 1 trial (68 weeks, 2.4 mg dose), participants lost ~15% body weight vs. 2.4% on placebo. In the 2024 SURMOUNT-5 head-to-head trial (72 weeks), it achieved 13.7% loss in adults with obesity (no diabetes).
Tirzepatide: Outperforms semaglutide in direct comparisons. SURMOUNT-1 (72 weeks, 15 mg) showed ~22.5% loss. In SURMOUNT-5, 20.2% loss (47% greater relative reduction than semaglutide), with 81% achieving ≥15% loss vs. 58% for semaglutide.
Retatrutide: Phase 2 data (48 weeks) indicate 24% average loss at higher doses (8-12 mg), surpassing both in separate studies. A 2025 systematic review ranked it highest (22% loss vs. 18% for tirzepatide, 14% for semaglutide). Ongoing phase 3 trials (e.g., TRIUMPH-1) focus on obesity without diabetes.
Which one is best for you?
